Neuroscience Therapeutic Area Strategy

A VP at a major biopharma company was interested in defining his strategy in the neuroscience space. Looking for a more targeted way to assess the opportunity than big consulting firms could provide, he turned to BTG.

We deployed two ex-McKinsey life science strategists to develop a comprehensive therapeutic area strategy plan. Combining internal data with relevant secondary research, they worked with the client’s team to align around a defined set of priorities, establish target product profiles (TPPs) for each, and share with senior management.

Value: A comprehensive therapeutic area strategy with specific target product profiles

About the Author

Leah Hoffmann

Leah Hoffmann is BTG's Content Strategist. A former journalist, Leah worked for Forbes.com and The Economist before joining BTG. She is passionate about clear thinking, sharp writing, and strong points of view.

More Content by Leah Hoffmann
Previous Article
Reinventing Consulting at an F200 Biopharma Company
Reinventing Consulting at an F200 Biopharma Company

Leaders at this biopharma giant didn’t set out to reinvent the way the company sourced industry experts and...

Next Article
Market Access Innovations: Pharmaceutical Affordability
Market Access Innovations: Pharmaceutical Affordability

Affordability is a major concern in health and life science—and not just in the U.S. In 2018, total prescri...